Prosperity & Valor WeeklyFollow via RSS
PVweekly.com
Research & Opportunities

NIH clarifies business-assistance funding after SBIR and STTR renewal

2026 archive · The April notice allowed eligible awardees to request help with commercialization, with limits of $6,500 per Phase I project and $50,000 per Phase II project.

By PV Weekly Editorial 1 min read
Share LinkedIn X Facebook
The NIH Clinical Center on the Bethesda campus, 2014. File photo.
The NIH Clinical Center on the Bethesda campus, 2014. File photo. Photo: NIH Image Gallery from Bethesda, Maryland, USA · Public domain · resized

Small businesses with federal research awards may need a manufacturing or regulatory plan as much as another experiment. An April 20, 2026, NIH notice explained how eligible SBIR and STTR recipients could request funding for that work.

The notice followed the April 13 signing of the Small Business Innovation and Economic Security Act. SBA said the law reauthorized Small Business Innovation Research and Small Business Technology Transfer through September 30, 2031. The extension preserved the programs’ authority; individual solicitations and awards remained separate decisions.

NIH’s Technical and Business Assistance policy applied to HHS awards and supplements made on or after April 13. It allowed requests of up to $6,500 for a Phase I project and $50,000 for a Phase II project, measured across all years of each project rather than annually.

Supported activities included market research, cybersecurity assistance, intellectual-property protection and regulatory or manufacturing plans. Recipients could use vendors or specified staffing and training arrangements. General bookkeeping and audit services were excluded, and Commercialization Readiness Pilot recipients were ineligible.

Applicants had to request and justify the assistance. Existing recipients could seek an administrative supplement for needs identified after an award; NIH institutes and centers retained discretion to decline.

Sources